Related by context. All words. (Click for frequent words.) 75 Recombinant Human 73 Receptor Antagonists 72 Signaling Pathway 72 Kinase Inhibitor 72 Reductase 72 Receptor Agonist 71 Chemokine Receptor 71 Cannabinoid 71 Drug Candidate 71 Tyrosine 71 Proteasome 70 Protein Kinase 70 Inhibits 70 Anti Tumor 70 Aurora Kinase 70 Benign Prostatic Hyperplasia 70 Epidermal Growth Factor Receptor 70 Inhibitors 70 Synthetic Peptide 70 Histone Deacetylase 70 Transdermal Patch 70 Dendritic Cells 70 Intracellular 70 Small Molecule 70 Monoclonal Antibody 69 Dehydrogenase 69 Present Preclinical Data 69 Androgen Receptor 69 Phase 2a Clinical Trial 69 Angiogenic 69 IND Application 69 Interferon Beta 69 Incretin 69 Replacement Therapy 69 Histone 69 Analogues 69 Modulates 69 Granulocyte Colony Stimulating Factor 69 Neuroprotective 69 Superoxide 69 Tumor Necrosis Factor 69 Smooth Muscle 69 Systemic Delivery 68 Pegylated 68 Cytotoxic 68 Efficacious 68 Prolongs Survival 68 Polymorphism 68 Antifungal 68 Catenin 68 Anti Inflammatory 68 Prodrugs 68 Clinical Trial Results 68 Prodrug 68 Immunomodulatory 68 Transdermal Delivery 68 JAK Inhibitor 68 Interferon Alpha 68 Receptor Agonists 68 Novel Mechanism 68 Antitumor 68 Estrogen Receptor 68 Antagonists 68 Factor Receptor 68 Mimetics 68 Synthase 68 Plasmid DNA 67 Tyrosine Kinase Inhibitor 67 Induces 67 Conjugate 67 Preclinical Data 67 Anti Tumor Activity 67 Controlled Trial 67 Androgen 67 Conjugated 67 Signaling Pathways 67 Transcription Factor 67 Phase 2a Trial 67 Prostate Cancer Cells 67 Cytochrome P# 67 Interferon Gamma 67 Adjuvant Treatment 67 Tocopherol 67 Angiotensin Converting Enzyme 67 Upregulation 67 Novel Oral 67 Subunit 67 Haemophilus b Conjugate 67 Calcitonin 67 Neuroprotective Effects 67 Sevelamer 67 Pharmacokinetic Study 67 Tumor Suppressor 67 Transgenic Mice 67 deoxy 67 humanized monoclonal 67 Beta Amyloid 67 Attenuates 67 Immune Responses 67 Vitro Activity 67 Mouse Model 67 Carcinomas 67 Kinase Inhibitors 67 Cyclooxygenase 2 67 Endothelial Cells 67 Phase 2b Trial 67 Hypertensive Patients 67 Potent Anti 67 Monotherapy 67 Parathyroid Hormone 67 Low Dose 67 Protease Inhibitors 67 topically administered 67 Protease Inhibitor 67 Nucleotide 66 Skeletal Muscle 66 Somatostatin 66 Inhibit 66 Tyrosine Kinase 66 Macrophage 66 Sapacitabine 66 Leukotriene 66 Phosphorylation 66 Novel Therapeutic 66 Medoxomil 66 Nucleoside 66 Unfractionated Heparin 66 Genotypes 66 Beneficial Effects 66 Antitumor Activity 66 Cancer Cells 66 Hsp# Inhibitor 66 Alkaline Phosphatase 66 Receives Orphan Drug Designation 66 Metabolites 66 Receptor Antagonist 66 Transmembrane 66 5HT 66 Presents Preclinical Data 66 Amino Acid 66 Immunotherapeutic 66 Pooled Analysis 66 Proteases 66 Preclinical Study 66 Microtubule 66 Study Evaluating 66 monophosphate 66 Potent Inhibitor 66 Microspheres 66 Orally Active 66 cytidine 66 Double Blind Randomized 66 Retinoic Acid 66 Secretion 66 Itraconazole 66 Cholesterol Lowering Drug 66 Protein Synthesis 66 Cell Adhesion 66 Secretase 66 Protease 66 Kinases 66 Phase 2b Clinical Trial 66 Tumor Targeting 66 Breast Cancer Metastasis 66 Mg Usa 66 downregulates 66 Therapeutic Targets 66 Interferon gamma 66 peptide CGRP 66 Anticancer Agent 66 Oligonucleotides 66 Therapeutic Potential 66 Nicotinic 66 Angiotensin 66 Breast Cancer Cells 66 Novel Antibiotic 66 TNF Alpha 66 Phase III Clinical Trial 66 Antiangiogenic 66 Well Tolerated 66 Oral Formulation 66 ergot derivatives 65 Pivotal Phase 65 Non Responders 65 See CLINICAL PHARMACOLOGY 65 Conjugates 65 Prostatic 65 Fibroblast Growth Factor 65 Aerosolized 65 Inhibitory 65 acyltransferase 65 Novel Anti Inflammatory 65 Biomolecules 65 Tezampanel 65 Cell Proliferation 65 Glucocorticoid 65 Allergic Rhinitis 65 Brain Metastases 65 Files IND 65 Shows Promise Against 65 Assay Kits 65 Previously Treated 65 Mg Uk 65 Autoantibodies 65 palmitoyl 65 Fibrinogen 65 Single Dose 65 uricase 65 Combination Therapy 65 Prophylactic Treatment 65 Therapeutic Vaccine 65 Fluorouracil 65 Phosphodiesterase 65 Metastatic Melanoma 65 Patients Treated With 65 Interferon Alfa 65 Antiviral Activity 65 Pharmacodynamics 65 Sustained Release 65 beta3 65 TNF Blockers 65 N methyl 65 Shows Promising 65 Dose Response 65 Glycine 65 Meets Primary Endpoint 65 Fibroblast 65 Oral Insulin 65 Therapeutic Effects 65 Adjuvant Therapy 65 Novel Inhibitor 65 Tumor Growth 65 Randomized Phase 65 Inflammatory Diseases 65 Oral Fingolimod 65 Formoterol 65 Neurotransmitter 65 Kinase 65 Antibacterials 65 AnaSpec Introduces 65 Posaconazole 65 Inflammatory Markers 65 Phospholipase A2 65 Contrast Agents 65 Peritoneal 65 Integrase 65 Capecitabine 65 Mouse Models 65 Hepatocellular Carcinoma 65 Allogeneic 65 HDAC Inhibitor 65 Demonstrates Potent 65 Transcriptome 65 Patent Covering 65 pan HDAC inhibitor 65 Complicated Skin 65 Clinical Outcome 65 Improves Survival 65 Sulfonylurea 65 Polymorphisms 65 HER2 HER3 65 Insulin Glargine 65 Demonstrates Potential 65 Suppresses 65 Liposomal 65 Tubulin 65 colony stimulating factor 65 Treating Chronic 65 Diabetic Nephropathy 65 Safinamide 65 Lanthanum Carbonate 65 Improve Survival 65 Fondaparinux 65 Combination Treatment 65 phosphatidylinositol 3 65 Infected Patients 65 Protein Kinase C 65 ACE Inhibitors 65 Orally administered 65 Placebo Controlled Trial 65 cytochrome P 65 Pafuramidine 64 Progenitor Cells 64 Statistically Significant 64 DNA intercalator 64 Genes Involved 64 Buccal 64 TNF Tumor Necrosis Factor 64 Myeloid 64 protein tyrosine phosphatase 1B 64 Adefovir 64 Lipid Levels 64 Monocytes 64 Initiate Phase 64 Dasatinib 64 xanthine 64 Hormone Refractory Prostate Cancer 64 Oral Spray 64 Phase III Clinical Trials 64 Biosynthesis 64 Epoetin 64 Inactivation 64 prostaglandin E 64 Endothelial 64 ACC2 64 Protein Function 64 Preclinical Models 64 Allosteric 64 Generic Version 64 Thiazolidinediones 64 PEGylated anti 64 Diabetic Neuropathy 64 Novel Method 64 Selective Inhibitor 64 CYP#A# CYP#D# 64 Slow Progression 64 Anti Inflammatory Drug 64 FDA Approvals 64 Effectively Treats 64 Inhaled Corticosteroids 64 Bortezomib 64 Anti Inflammatory Drugs 64 cyclin dependent kinase inhibitor 64 selective antagonist 64 sodium glucose cotransporter 64 Subtypes 64 FDA Okays 64 Gene Silencing 64 Demonstrates Efficacy 64 cyclooxygenase 64 Kidney Function 64 Aptamer 64 Renal Cell Carcinoma 64 Antisense Oligonucleotides 64 Fluticasone 64 Bosutinib 64 Insulin Resistance 64 GLP1 64 cytochrome p# 64 calcitonin gene related 64 Hematopoietic 64 Epithelial 64 Uric Acid 64 Glycoprotein 64 Methylnaltrexone 64 Phase IIb Clinical Trial 64 Anthracycline 64 Nitric Oxide Synthase 64 Protelos R 64 murine model 64 Differentially 64 Tiotropium 64 Secretory 64 thrombin receptor 64 receptor modulators 64 somatostatin 64 Lipase 64 Maleate 64 Glucagon Like Peptide 64 cell adhesion molecule 64 Phase IIa Clinical Trial 64 Significantly Improved 64 Cytochrome 64 Novel Protein 64 prostanoid 64 Antigens 64 Disease Modifying 64 Metastases 64 antisense oligonucleotide 64 Epitopes 64 Antigen Specific 64 Neurogenesis 64 Lung Cancer Drug 64 P2X 64 monocyte chemotactic protein 64 Phase 2b Study 64 Oligonucleotide 64 Multidrug Resistance 64 Investigational Compound 64 Neural Stem Cells 64 Fracture Risk 64 Epoetin Alfa 64 Gene Mutation 64 Highly Potent 64 Hypercholesterolemia 64 novel VDA molecule 64 Gene Variants 64 Improves Outcomes 64 hydrolase 64 Completes Patient Enrollment 64 Platelet Derived Growth 63 Dose Ranging Study 63 tricyclic 63 Is Well Tolerated 63 Budesonide 63 Adjunctive Therapy 63 Glycosylation 63 Antidiabetic 63 Immunostimulatory 63 Autoimmune Disorders 63 Polyethylene Glycol 63 Tacrolimus 63 Antisense 63 First Patient Dosed 63 Elevated Levels 63 Polymerase Inhibitor 63 Irinotecan 63 Anticancer Drug 63 Analgesic 63 Anticoagulants 63 Cyclooxygenase 63 Nanoemulsion 63 antimitotic 63 Proves Effective 63 Enzymatic 63 Chronic Sinusitis 63 hydroxymethyl 63 beta 1a 63 Protein Expression 63 androgen receptor AR 63 EGFR HER2 63 Hepatocytes 63 Glatiramer Acetate 63 Radiofrequency Ablation 63 benzimidazole 63 RNA Interference 63 Inflammatory Arthritis 63 Drug Resistant 63 Autologous Stem Cell Transplantation 63 Chemoradiation 63 Initiates Clinical Trial 63 Glutamic Acid 63 Initiates Clinical 63 rivastigmine Exelon 63 mediated apoptosis 63 Immune Cells 63 Tartrate 63 hydroxylase 63 converting enzyme 63 Immunogenic 63 Secondary Hyperparathyroidism 63 Lowers Risk 63 Murine Model 63 Phosphatase 63 Monoclonal Antibodies 63 Serious Infections 63 ,#,# [002] 63 Advanced Renal Cell 63 Initiate Clinical Trial 63 5alpha reductase 63 Nitric Oxide 63 Amniotic Fluid 63 cytotoxic effects 63 Cardiotoxicity 63 Therapeutic Antibody 63 Lung Cancer Trial 63 Treatment Naïve 63 Respiratory Virus 63 Novel Small Molecule 63 Tumor Cells 63 selective inhibition 63 mediated inhibition 63 Chronic Hepatitis B 63 Modulating 63 Predict Response 63 Binding Protein 63 Mutational 63 Cholinesterase Inhibitors 63 Conformational 63 Controlled Clinical Trial 63 Submits NDA 63 Diabetic Patients 63 monocytes macrophages 63 Myelodysplastic Syndromes 63 Inhibitor 63 Neuroprotection 63 generation antisense inhibitor 63 Atopic Dermatitis 63 Adenoviral 63 glucosidase 63 Appears Safe 63 Oncolytic 63 HDAC enzymes 63 acyl CoA 63 Rotavirus Vaccine 63 Brain Cells 63 Phase IIb Trial 63 Oxidase 63 adrenergic receptors 63 Successfully Completes Phase 63 Unresectable 63 anti CD3 63 Angiotensin II 63 peroxidase 63 Lymphoid 63 cyclooxygenase COX 63 Extracellular 63 Protein Kinase Inhibitors 63 Soft Tissue Sarcoma 63 RNAi Therapeutics 63 Diabetic Foot Ulcer 63 Osteoporosis Drug 63 Blood Pressure Drug 63 Fewer Side Effects 63 Induces Apoptosis 63 Cancer Vaccines 63 Benzyl 63 Assay Kit 63 chemokine receptor 63 RNAi Therapeutic 63 Meta Analysis 63 Disease Progression 63 Quantitation 63 Malignancies 63 Treatment Naïve Patients 63 Supplemental Figure 63 Pathway Inhibitor 63 NDA Submission 63 Paraplatin ® 63 Non Inferiority 63 Bazedoxifene 63 enzyme inhibitors 63 chemokine receptors 63 Monoclonal 63 HER1 63 Technosphere ® 63 1α 63 diphosphate 63 Soy Isoflavones 63 Prostaglandin 63 DNA Methylation 63 Randomized Clinical Trial 63 p# mitogen activated 63 Mesenchymal Stem Cells 63 Targeted Therapies 63 Genetic Mutation 63 neurokinin 63 Nitazoxanide 63 lovastatin Mevacor 63 Efficacy Trial 63 Innate Immune 63 Hydroxy 63 Data Suggest 63 Presents Preclinical 62 MTHFR 62 Excretion 62 abacavir Ziagen 62 Rheumatoid Arthritis Patients 62 Human Monoclonal Antibody 62 Myeloperoxidase 62 Bronchodilator 62 beta actin 62 Breast Tumors 62 Clinical Study Shows 62 Biosimilar 62 Protein Interactions 62 Leukemias 62 Chimeric 62 Levels Linked 62 Antithrombin 62 Virus Infection 62 cis retinoic acid 62 Fungal Infections 62 Refractory Hodgkin Lymphoma 62 Mutagenesis 62 N acetyl 62 Treated Patients 62 Erythropoietic 62 Adenoma 62 Erythropoietin 62 Anti Angiogenic 62 Pivotal Study 62 Peginterferon 62 Galectin 62 CDK inhibitor 62 selective modulator 62 mitogen activated protein kinase 62 Patients Receiving 62 Indole 62 Cytotoxicity 62 Atypical Antipsychotic 62 Fluconazole 62 proteasome inhibitor 62 PI3 62 Arginine 62 receptor blocker 62 Elvitegravir 62 Plus Ribavirin 62 Fulvestrant 62 Hepatitis B Vaccine 62 matrix metalloproteases 62 Beta Blocker 62 Anticancer Activity 62 Tyrosine Kinase Inhibitors 62 Oxidative Stress 62 Anticoagulant 62 siRNA Delivery 62 Decitabine 62 Glucocorticoids 62 Integrin 62 Cysteine 62 Clinical Relevance 62 Galantamine 62 Tigecycline 62 Aspartate 62 Lymphocytic 62 Clusterin 62 pyrimidines 62 Drug Shows Promise 62 Transfection 62 PPARg 62 Chronic Hepatitis C 62 Fibrates 62 cytokine receptor 62 Prognostic Significance 62 Relapsed Refractory 62 Genetic Variation 62 Oncogenic 62 cromolyn sodium 62 Develop Novel 62 Universal Flu Vaccine 62 Antipsychotic 62 Nedd4 62 nucleoside analog 62 Degarelix 62 Completes Enrollment 62 phospholipase 62 Phytosterol 62 pyridoxine 62 mesylate 62 Protein Biomarkers 62 serine protease 62 NS#/#A protease 62 Transcriptional 62 Alanine 62 Ligands 62 interleukin IL -# 62 Initiates Phase 62 Long Term Efficacy 62 Nilotinib 62 Vidaza azacitidine 62 Hyperlipidemia 62 Demonstrated Significant 62 selectively inhibited 62 Bone Morphogenetic Protein 62 Effective Than 62 Serum concentrations 62 Amino acid 62 Antiviral Therapy 62 Antiplatelet 62 Immunoassays 62 Tumor Angiogenesis 62 Magnetic Nanoparticles 62 Azacitidine 62 Nicotine Vaccine 62 Janus kinase 62 Clinical Trial Evaluating 62 Lowers Blood Pressure 62 IGF1R 62 Cytotoxic T 62 Crit Rev 62 Viral Load 62 Peginterferon Alfa 2a 62 receptor blockers 62 Botulinum Toxin 62 Impairs 62 Cytoplasmic 62 Cilostazol 62 Salivary 62 Trial Evaluating 62 Gene Linked 62 Relapsing Multiple Sclerosis 62 Pharmacokinetics PK 62 Liver Injury 62 Hepatic Encephalopathy 62 intravesical instillation 62 Darinaparsin 62 SGLT 62 Demonstrates Significant 62 Fatty Acid 62 Significantly Improves 62 Survival Benefit 62 Vitamin B3 62 Enzyme Linked 62 Improved Survival 62 Enzyme Replacement Therapy 62 Bile Acid 62 Hormonal Therapy 62 Vascular Inflammation 62 inhibitor COX 62 Controlled Study 62 S#P# 62 Protein Involved 62 Roche Boniva 62 Cell Differentiation 62 Oxidative 62 N Acetyl 62 novel prodrug 62 Genotyping Test 62 Investigational Treatment 62 2 inhibitor CYT# 62 Treatment Reduces 62 Calcineurin 62 Camptothecin 62 Shows Efficacy 62 Vildagliptin 62 Capsular 62 Commences Phase 62 FDA Clears 62 liposome encapsulated 62 Febuxostat 62 glucoside 62 Stent Restenosis 62 Haloperidol 62 Fluticasone Propionate 62 MEK1 62 angiopoietin 62 mineralocorticoid receptor 62 Sublingual 62 Investigational Drug 62 serine threonine 62 SAR# [002] 62 mimetic peptide 62 Streptococcus agalactiae 62 malate 62 ergot alkaloids 62 IgG1 62 Personalized Immunotherapy 62 Riboflavin 62 Effective Treatments 62 Advanced Melanoma 62 PEGylated Fab fragment 62 antiapoptotic 62 Antiarrhythmic 62 Adsorption 62 KL4 Surfactant 62 VEGF inhibitors 62 Oral Anticoagulant 62 Proliferative 62 Interferons 62 Knee Osteoarthritis 62 Naturally Occurring 62 Nat Clin Pract 62 Flt3 62 Albumin 62 Hepatitis B Virus 62 Reduces Pain 62 Recombinant Protein 62 Ziprasidone 62 Adjuvant Chemotherapy 62 reverse transcriptase inhibitors 62 Monopril 62 Endoplasmic Reticulum 62 iobenguane 62 Advanced Colorectal Cancer 61 Investigational Agent 61 Treatment Regimens 61 Hydrochloride Injection 61 Small Molecule Inhibitors 61 Biomarker Panel 61 Antiepileptic 61 Interferon alfa 61 pharmacokinetic interactions 61 lipoxygenase 61 Cancer Stem Cells 61 immunostimulatory 61 Pramlintide 61 Apoptotic 61 semisynthetic 61 Randomized Study 61 Premature Aging 61 biguanide 61 FK# 61 induces apoptosis 61 Polysaccharides 61 Placebo Controlled Study 61 Novel Treatments 61 Phase Ib Clinical Trial 61 Endothelin 61 LNCaP cells 61 aminolevulinic acid 61 Phase 1b Clinical Trial 61 Cholesterol Lowering 61 Leukocyte 61 monoamine oxidase inhibitors 61 vimentin 61 Holds Promise 61 Pegylated Interferon 61 insulin sensitizers 61 Infectivity 61 Endothelial Cell 61 Cardiomyocytes 61 Antisense Drug 61 Mycophenolate Mofetil 61 Postmenopausal Women 61 Lentiviral 61 Endometrial 61 Immunogenicity 61 Nucleic Acid 61 Tofranil 61 Novel Compound 61 Neutralizing Antibodies 61 Chemotherapeutic Agents 61 Vinorelbine 61 Gram Positive 61 SSAO 61 Preclinical studies suggest 61 dopamine D2 61 #,# dimethyl 61 Adjuvanted 61 Prostacyclin 61 nizatidine 61 Lipodystrophy 61 Topical Treatment 61 Pediatric Patients 61 CD# CD# 61 glutamyl 61 peroxisome proliferator activated 61 Antiviral Drugs 61 pDC 61 Aldosterone 61 CYT# potent vascular disrupting 61 selective phosphodiesterase 61 Poster Presentations 61 Patients Suffering 61 Bevacizumab 61 matrix metalloproteinases 61 Inhalation Solution 61 Ecallantide 61 Phenylalanine 61 Retroviral 61 Cutaneous T 61 Patients Treated 61 cetuximab Erbitux R 61 Vaginal Gel 61 Humanized Anti 61 Confirmatory Phase 61 Late Breaker 61 Cellular Immunotherapy 61 ERK signaling 61 Preclinical Evaluation 61 Presents Positive 61 selective agonist 61 II Clinical Trial 61 Peptide YY 61 Lipoprotein 61 Topoisomerase 61 JAK2 enzyme 61 multikinase inhibitor 61 PPARgamma 61 extracellular signal 61 null mice 61 Advanced Prostate Cancer 61 Prospective Randomized 61 Therapeutic Agents 61 Hematopoietic Stem Cells 61 Plaque Psoriasis 61 Phase III Trials 61 Mesalamine 61 antiproliferative effects 61 interferon IFN 61 Dimethyl 61 Cetrorelix 61 replicase 61 Abdominal Fat 61 Diabetic Neuropathic Pain 61 p# MAPK 61 Generic Versions 61 Gene Variant 61 Quantum Dots 61 Carnosine 61 Hepatitis C Genotype 61 liposomal formulation 61 5 hydroxytryptamine 61 N acetyl glucosamine 61 Oxidized 61 phosphoprotein 61 Malic Acid 61 Aplidin R 61 Combination REOLYSIN R 61 Breast Cancer Recurrence 61 Hepatocellular 61 Gastrointestinal Stromal Tumors 61 coenzyme 61 Anticancer Drugs 61 Molecular Mechanism 61 Temsirolimus 61 Epithelium 61 CYP#A# inhibitors 61 thromboxane A2 61 Mucosal 61 Endothelial Function 61 Basal Insulin 61 MET VEGFR2 61 Phospholipid 61 JAK2 Inhibitor 61 Nucleic Acids 61 Immune Cell 61 Hormone Receptor Positive 61 Epilepsy Drug 61 covalently bound 61 Vaprisol 61 octreotide acetate 61 HMG CoA reductase inhibitors 61 Exemestane 61 Cerebrospinal Fluid 61 Gene Variation 61 Neoplasms 61 Therapeutic Efficacy 61 Crystallographic 61 Blood Pressure Lowering 61 Postmenopausal Osteoporosis 61 Melphalan 61 beta. 61 Hepatitis C Virus 61 Osteoporosis Treatment 61 Migraine Drug 61 capsular polysaccharide 61 adipogenic 61 Losartan 61 Extended Release 61 microsomal 61 histone deacetylase inhibitor 61 Cytokines 61 Muscarinic 61 potently inhibit 61 Estrogen Therapy 61 Reduces Risk 61 Neurol 61 glycogen synthase kinase 61 cholesteryl ester transfer 61 irreversible inhibitor 61 Interferon alpha 61 TLK# 61 Chitosan 61 BMP2 61 Phase III Trial 61 Guanilib 61 Seasonal Influenza Vaccine 61 Isavuconazole 61 regulated kinase 61 hPTH #-# 61 LHRH 61 Higher Doses 61 cyclic nucleotide 61 HepG2 cells 61 TGF Beta 61 Trandolapril 61 downstream effector 61 PKC# 61 Genes Linked 61 small molecule activator 61 Bioavailability 61 Collaborators Publish 61 Janus Kinase 61 EP4 61 Inositol 61 Intravascular 61 Metabolic Disease 61 Lung Tumors 61 Am J Clin 61 Glucagon 61 interleukin IL 61 R Saizen R 61 PRN FDA Approves 61 Breast Cancers 61 vitro assay 61 Conjugate Vaccine 61 quinoline 61 Gout Drug 61 GW# [003] 61 Thrombin 61 Gastric Cancer 61 Trodusquemine MSI 61 Ion Channels 61 Drug Combo 61 Biotin 61 Frizzled 61 T Lymphocytes 61 Lamotrigine 61 ara C 61 Blinatumomab 61 soluble tumor necrosis 61 inverse agonist 61 targeted antifolate 61 Gly 61 mTOR inhibitors 61 proteasome inhibitors 61 P2Y 61 metalloproteinase 61 Carbamazepine 61 Mylan Receives Approval 61 Homeostasis 61 Cardiac Troponin 61 SGLT2 61 exendin 4 61 Metastatic Prostate Cancer 61 Electrical Stimulation 61 Chemotherapeutic